ReNeuron receives clearance for stem cell trial

Wednesday 10 February 2010

The ReNeuron Group Plc has received final regulatory clearance to start its ground-breaking first-in-man study of a stem cell therapy for stroke. The therapy will be administered to patients who have been left disabled by an ischaemic stroke.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom